References
- Ahmad, S. (2009). Anticholinergics and amantadine. In V. A. Sadock, B. J. Sadock, & P. Ruiz (Eds.), Kaplan & Sadock's comprehensive textbook of psychiatry (9th ed., Vol. 2, pp. 3014–3021). Philadelphia, PA: Lippincott Williams & Wilkins.
- Ali, S., & Milev, R. (2003). Switch to mania upon discontinuation of antidepressants in patients with mood disorders: A review of the literature. Canadian Journal of Psychiatry, 48, 258–264. Retrieved September 9, 2013, from http://www.ncbi.nlm.nih.gov/pubmed/12776393
- Ben Hadj Ali, B., Dogui, M., Ben Ammou, S., & Loo, H. (1995). Antiparkinson drugs in neuroleptic treatment: Comparative study of progressive and abrupt withdrawal. Encephale, 21, 209–215. Retrieved September 9, 2013, from http://www.ncbi.nlm.nih.gov/pubmed/?term=Antiparkinson+drugs+in+neuroleptic+treatment%3A+comparative+study+of+progressive+and+abrupt+withdrawal
- Fisch, R. Z. (1987). Trihexyphenidyl abuse: Therapeutic implications for negative symptoms of schizophrenia? Acta Psychiatrica Scandinavica, 75, 91–94. Retrieved September 9, 2013, from http://www.ncbi.nlm.nih.gov/pubmed/?term=Trihexyphenidyl+abuse%3A+therapeutic+implications+for+negative+symptoms+of+schizophrenia doi: 10.1111/j.1600-0447.1987.tb02757.x
- Jellinek, T. (1977). Mood elevating effect of trihexyphenidyl and biperiden in individuals taking antipsychotic medication. Diseases of the Nervous System, 38, 353–355. Retrieved September 9, 2013, from http://www.ncbi.nlm.nih.gov/pubmed/?term=Mood+elevating+effect+of+trihexyphenidyl+and+biperiden+in+individuals+taking+antipsychotic+medication
- Jellinek, T., Gardos, G., & Cole, J. O. (1981). Adverse effects of antiparkinson drug withdrawal. American Journal of Psychiatry, 138, 1567–1571. Retrieved September 9, 2013, from http://www.ncbi.nlm.nih.gov/pubmed/6118066
- Macvicar, K. (1977). Abuse of antiparkinsonian drugs by psychiatric patients. American Journal of Psychiatry, 134, 809–811. Retrieved September 9, 2013, from http://www.ncbi.nlm.nih.gov/pubmed/869063
- Marriott, P. (1976). Letter: Dependence on antiparkinsonian drugs. British Medical Journal, 1, 152. Retrieved September 9, 2013, from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1638655/pdf/brmedj00499-0048c.pdf doi: 10.1136/bmj.1.6002.152-b
- Marriott, P., & Hiep, A. (1978). Drug monitoring at an Australia depot phenothiazine clinic. Journal of Clinical Psychiatry, 39, 206–212. Retrieved September 9, 2013, from http://www.ncbi.nlm.nih.gov/pubmed/?term=Drug+monitoring+at+an+Australia+depot+phenothiazine+clinic
- Smith, J. M. (1980). Abuse of the antiparkinson drugs: A review of the literature. Journal of Clinical Psychiatry, 41, 351–354. Retrieved September 9, 2013, from http://www.ncbi.nlm.nih.gov/pubmed/7430078
- Woody, G. E., & O'Brien, C. P. (1974). Anticholinergic toxic psychosis in drug abusers treated with benztropine. Comprehensive Psychiatry, 15, 439–442. doi:0010-440X(74)90043-1 [pii] doi: 10.1016/0010-440X(74)90043-1
- Zemishlany, Z., Aizenberg, D., Weiner, Z., & Weizman, A. (1996). Trihexyphenidyl (Artane) abuse in schizophrenic patients. International Clinical Psychopharmacology, 11, 199–202. Retrieved September 9, 2013, from http://www.ncbi.nlm.nih.gov/pubmed/8923099 doi: 10.1097/00004850-199609000-00007